NTSR1

Chr 20

neurotensin receptor 1

Also known as: NTR

Neurotensin receptor 1 is a G-protein coupled receptor that binds the neuropeptide neurotensin and activates phosphatidylinositol-calcium signaling pathways, regulating functions including blood pressure, glucose metabolism, temperature control, pain perception, and intestinal motility. Mutations cause neurodevelopmental disorder with hypotonia, language delay, and malformations, inherited in an autosomal recessive pattern. This gene shows very low constraint against loss-of-function variants, consistent with recessive inheritance where heterozygous carriers are typically unaffected.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
44
Pubs (1 yr)
28
P/LP submissions
0%
P/LP missense
1.37
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryNTSR1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
28 unique Pathogenic / Likely Pathogenic· 91 VUS of 143 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.37LOEUF
pLI 0.000
Z-score 0.49
OE 0.86 (0.561.37)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.42Z-score
OE missense 1.07 (0.971.17)
310 obs / 290.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.86 (0.561.37)
00.351.4
Missense OE1.07 (0.971.17)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 13 / 15.1Missense obs/exp: 310 / 290.1Syn Z: 0.66
DN
0.74top 25%
GOF
0.81top 10%
LOF
0.3454th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

143 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic6
VUS91
Likely Benign9
Benign10
22
Pathogenic
6
Likely Pathogenic
91
VUS
9
Likely Benign
10
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
22
0
22
Likely Pathogenic
0
0
6
0
6
VUS
0
76
15
0
91
Likely Benign
0
2
2
5
9
Benign
0
6
1
3
10
Total084468138

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NTSR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →